Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT05218694
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 and \< 81 years
* Stable angina
* at least 1 vessel disease in either the left coronary artery or right coronary artery
* Stenosis grater than 50% and no stenosis greater than 40% on contralateral vessel unless fractional flow reserve by CT (FFRct) \>0.80
* Vessel segment \> 2 mm in diameter
* Subject eligible for Dual Anti Platelet Therapy (DAPT
Exclusion Criteria:
* Significant bleeding risk or other contraindications against heparinization or DAPT
* Known pregnancy
* Life expectancy \< 120 days
* Patient unable to provide informed consent
* Patients with CTO (Chronic Total Occlusion).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05218694
Study Brief:
Protocol Section:
NCT05218694